ReviewEuropean clinical respiratory journal2018

Efficacy, adverse events, and inter-drug comparison of mepolizumab and reslizumab anti-IL-5 treatments of severe asthma - a systematic review and meta-analysis.

Daniel P Henriksen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.